Janet Englund

Credentials: · ·

History

IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses
NCIRD · U01
Contact PI · $12.3M · Seattle Children's Hospital
2021–2027
Multi-Center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients
National Institute of Allergy and Infectious Diseases · R01
PI · $4.1M · Arkansas Children's Hospital Res Inst
2021–2027
Enhanced Surveillance for New Vaccine Preventable Diseases
NCIRD · U01
Contact PI · $6.3M · Seattle Children's Hospital
2016–2021
Enhanced Surveillance for New Vaccine Preventable Disease
NCIRD · U01
Contact PI · $3.3M · Seattle Children's Hospital
2011–2017

Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine
Principal investigator · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2011–2015
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure
Principal investigator · Completed · Phase 4
Seattle Children's Hospital
2009–2013
Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age
Study chair · Completed · Phase 2, Phase 3
Seattle Children's Hospital
2005–2007